UNSPSC 41202049: Rabiesvirus immunofluorescent reagents

In this classification, Rabiesvirus immunofluorescent reagents are devices used in test to identify specific Rabiesvirus immunofluorescent reagents antibodies in serum. US FDA regulates Rabiesvirus immunofluorescent reagents under 21 CFR 866.3460 and under FDA product code GOI.

UNSPSC 41202049 Rabiesvirus immunofluorescent reagents (Commodity) shows minimal recent state and local procurement activity aligned with its nominal scope. Of nine recent opportunities tagged to this code, only one directly addresses the code's stated product — rabies-specific diagnostic reagents — while the remainder involve unrelated clinical laboratory testing, drug testing supplies, and HIV/Syphilis testing reagents. The single tangentially relevant opportunity does not constitute sufficient signal to characterize active demand under this Commodity code. State and local procurement bodies do not appear to be actively soliciting rabies immunofluorescent reagent supplies through recent public notices.

The recent opportunities in the dataset primarily reflect diagnostic laboratory testing services and reagents for sexually transmitted infection screening, drug abuse testing, and general clinical laboratory work across Illinois, Texas, and Georgia jurisdictions. The Illinois Department of Public Health, Collin County (Texas), the City of Austin, and Gwinnett County (Georgia) are issuing bodies active in laboratory reagent and testing-service procurement during the period reviewed, but their focus centers on HIV, syphilis, and drug-abuse testing reagents rather than rabies diagnostics. Without recent evidence of state or local demand for rabiesvirus immunofluorescent reagent supplies, this code does not present a current pursuit opportunity in the state and local market.